AmacaThera is a biotechnology company focused on developing and commercializing a unique, injectable hydrogel platform technology for a wide range of medical applications. The company has developed a platform technology that addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas, inclucing post-surgical pain management, cancer and other hard-to-reach targets. Based on the research of world-renowned biomaterials scientist, Dr. Molly Shoichet, AmacaThera is commercializing combination products at the interface of biomaterials and pharmaceuticals.